# Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5

> **NCT06196320** · PHASE3 · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 452 (actual)

## Conditions studied

- Ischemic Stroke, Acute

## Interventions

- **DRUG:** Tenecteplase
- **DRUG:** Best Practice (which may include intravenous Alteplase)

## Key facts

- **NCT ID:** NCT06196320
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-24
- **Primary completion:** 2025-09-11
- **Final completion:** 2025-09-22
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196320, "Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06196320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*